Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trial of CGM Technology in Persons Living With Prediabetes

NCT: NCT07639593 · NOT_YET_RECRUITING

NCT IDNCT07639593
StatusNOT_YET_RECRUITING
Start Date2026-08
Completion2027-03
SponsorWake Forest University Health Sciences (OTHER)
First posted
Last updated

Brief Summary

Continuous glucose monitor (CGM) technology has become increasingly prevalent in the population and has the ability to transform care of patients living with prediabetes. While the technology was initially utilized primarily by patients living with type 1 diabetes using insulin pump therapy, it has become more widely used as part of care in patients living with type 1 or 2 diabetes on any kind of insulin therapy.

Frequently Asked Questions

What is Trial of CGM Technology in Persons Living With Prediabetes?

Trial of CGM Technology in Persons Living With Prediabetes is a clinical trial registered under NCT07639593. Current status: NOT_YET_RECRUITING.

What is the status of NCT07639593?

The current status of NCT07639593 (Trial of CGM Technology in Persons Living With Prediabetes) is: NOT_YET_RECRUITING.

When did Trial of CGM Technology in Persons Living With Prediabetes start?

Trial of CGM Technology in Persons Living With Prediabetes started on 2026-08.

Related Devices

K201214t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K232380t:slim X2 Insulin Pump with Interoperable TechnologyTandem Diabetes Care, Inc. K250792t:slim X2 insulin pump with interoperable technologyTandem Diabetes Care, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑